Gastric Secretory Abnormalities in Duodenal Ulcer: Primary or Secondary to Helicobacter pylori Infection?

References

• Misiewicz J J. Helicobacter pylori: past, present, and future. Scand J Gastroenterol 1992; 27: 25–29, Suppl 194
   PubMed Web of Science ®Google Scholar
• Kovacs T OG, Soil A H. Pathophysiology of peptic ulcer disease. The stomach, S Gustavsson, D Kumar, D Y Graham. Churchill Livingstone, London 1992; 230–45
   Google Scholar
• Pounder R E, Prewett E J. Gastric secretion of health and disease. The stomach, S Gustavssons, D Kumar, D Y Graham. Churchill Livingstone, London 1992; 53–80
   Google Scholar
• Lam S K. Heterogeneous origin of hyperacidity in duodenal ulcer. Progr Clin Biol Res 1985; 173: 255–71
   PubMedGoogle Scholar
• Lamers C BHW. Hormonal regulation of gastric acid in peptic ulcer. Scand J Gastroenterol 1988; 23: 5–10, Suppl 146
   Web of Science ®Google Scholar
• Bianchi Porro G, Lazzaroni M. Medical treatment of peptic ulcer disease. The stomach, S Gustavsson, D Kumar, D Y Graham. Churchill Livingstone, London 1992; 246–65
   Google Scholar
• Rotter J I. Genetic approaches to ulcer heterogeneity. The genetics and heterogeneity of common gastrointestinal disorders, J I Rotter, I M Samloff, D L Rimoin. Academic Press, New York 1980; 111–28
   Google Scholar
• Rotter J I, Petersen G M, Samloff I M. Pepsinogens and other physiologic markers in genetic studies of peptic ulcer and related disorders. Progr Clin Biol Res 1985; 173: 227–44
   PubMedGoogle Scholar
• Rotter J I, Sones J Q, Samloff I M, et al. Duodenal ulcer disease associated with elevated serum pepsinogen I, an inherited autosomal dominant disorder. N Engl J Med 1979; 300: 63–6
   PubMed Web of Science ®Google Scholar
• Rotter J I, Petersen G M, Samloff I M, et al. Genetic heterogeneity of familial hyperpepsinogenemic I and normopep-sinogeic I duodenal ulcer disease. Ann Intern Med 1979; 91: 372–7
   PubMed Web of Science ®Google Scholar
• Taylor I L, Calam J, Rotter J I, et al. Family studies of hypergastrinemic hyperpepsinogenemic I duodenal ulcer. Ann Intern Med 1981; 95: 421–4
   PubMed Web of Science ®Google Scholar
• Lamers C BHW., Jansen J BMJ., Rotter J I, Samloff I M. Serum pepsinogen I in hereditery hypergastrinemic peptic ulcer syndromes. Progr Clin Biol Res 1985; 173: 273–81
   PubMedGoogle Scholar
• Byrnes D J, Lam S K, Sircus W. The relation between functioning parietal cell and gastric cell mass in two groups of duodenal patients. Clin Sci Mol Med 1976; 50: 375–83
   PubMedGoogle Scholar
• Fritsch W P, Hausamen T U, Rick W. Gastric and extragastric gastrin release in normal subjects, in duodenal ulcer patients and patients with partial gastrectomy (Billroth I). Gastroenterology 1976; 71: 552–7
   PubMed Web of Science ®Google Scholar
• Walsh J H, Richardson T, Fordtran J. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462–8
   PubMed Web of Science ®Google Scholar
• Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers; the gastrin link. Lancet 1989; 1: 1167–8
   PubMed Web of Science ®Google Scholar
• Smith J TL, Pounder R E, Nwokolo C U, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990; 31: 522–5
   PubMed Web of Science ®Google Scholar
• Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760–6
   PubMed Web of Science ®Google Scholar
• Prewett E J, Smith J TL, Nwokolo C U, Hudson M, Sawyer A M, Pounder R E. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther 1991; 5: 283–90
   PubMed Web of Science ®Google Scholar
• Chittajallu R S, Dorrian C A, Ardill J ES, McColl K EL. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992; 27: 20–4
   PubMed Web of Science ®Google Scholar
• McColl K EL, Fullarton G M, Chittajallu R, et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer patients. Scand J Gastroenterol 1991; 26: 339–46
   PubMed Web of Science ®Google Scholar
• Graham D Y, Opekun A, Lew G M, Klein P D, Walsh J H. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. Gastroenterology 1991; 100: 1571–5
   PubMed Web of Science ®Google Scholar
• Moss S F, Calam J. Changes in acid secretion and parietal cell sensitivity to gastrin in duodenal ulcer patients after eradication of Helicobacter pylori. Gut 1992; 32: S28
   Google Scholar
• Graham D Y, Opekun A, Lew G M, Evans D J, Klein P D, Evans D G. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter pylori infection. Am J Gastroenterol 1990; 85: 394–398
   PubMed Web of Science ®Google Scholar
• Fraser A G, Prewett E J, Pounder R E, Samloff I M. Twenty-four-hour hyperpepsinogenaemia in Helicobacter pylori-positive subjects is abolished by eradication of the infection. Aliment Pharmacol Ther 1992; 6: 389–94
   PubMed Web of Science ®Google Scholar
• Veldhuyzen van Zanten S JO, Tijtgat K MAJ., de Garra C J, et al. A prospective comparison of symptoms and five diagnostic tests in patients with Helicobacter pylori positive and negative dyspepsia. Eur J Gastroenterol Hepatol 1991; 3: 463–8
   Google Scholar
• Saffouri B, Weir C G, Bitar K N, Makhlouf G. Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides. Am J Physiol 1980; 238: 495–501
   PubMed Web of Science ®Google Scholar
• Schubert M L, Makhlouf G. Regulation of gastrin and somatostatin by intramural neurons; effect of nicotinic receptor stimulation with dimethyl-phenylpiperazinium. Gastroenterology 1982; 82: 626–32
   Google Scholar
• Saffouri B, Weir G., Makhlouf G. Stimulation of gastrin secretion by perfused rat stomach by somatostatin antiserum. Life Sci 1979; 25: 1749–54
   PubMed Web of Science ®Google Scholar
• Kishimoto S, Takaba N, Ogawa M, et al. Gastrin and somatostatin in patients with hyperchlorhydric duodenal ulcer. Hiroshima J Med Sci 1985; 34: 441–9
   PubMedGoogle Scholar
• Colturi T J, Unger R, Feldman M. Role of circulatory somatostatin in regulation of gastric secretion, gastrin release, and islet cell function: studies in healthy subjects and duodenal ulcer patients. J Clin Invest 1984; 74: 417–23
   PubMed Web of Science ®Google Scholar
• Chayvialle J AP, Descos F, Bernard C, Martin A, Barbe C, Partensky C. Somatostatin in mucosa of stomach and duodenum in gastroduodenal disease. Gastroenterology 1978; 75: 13–9
   PubMed Web of Science ®Google Scholar
• Sumii K, Fukushima T, Hirata T, et al. Antral gastrin and somatostatin concentrations in peptic ulcer patients. Peptides 1981; 2: 281–3, Suppl 2
   PubMedGoogle Scholar
• Torres A J, Fernandez-Durango R, Suarez A, et al. Gastric mucosal somatostatin-like immunoreactivity in peptic ulcer. Surg Gynaecol Obstet 1987; 164: 313–8
   Google Scholar
• Arnold R, Koop H, Schwarting H, Tuch K, Willemer B. Effect of acid inhibition on gastric endocrine cells. Scand J Gastroenterol 1986; 21: 14–9, Suppl 125
   Web of Science ®Google Scholar
• Polak J H, Bloom S R, Bishop H F, McGrossan M V. D-cell pathology in duodenal ulcers and achlorydria. Metabolism 1978; 27: 1239–42, Suppl 1
   PubMed Web of Science ®Google Scholar
• Harty R F, Maico D G, McGuigan J E. Antral release of gastrin and somatostatin in duodenal ulcer and control subjects. Gut 1986; 27: 652–8
   PubMed Web of Science ®Google Scholar
• Uvnas-Moberg K, Anderson B, Posloncec B. Initial fall in peripheral plasma somatostatin-like immunoreactivity levels following feeding in humans indicating a vagal inhibitory control of somatostatin levels. Acta Physiol Scand 1981; 113: 411–3
   PubMedGoogle Scholar
• Allen J M, Bishop A E, Daly M G, et al. Effect of inhibition of acid secretion on the regulatory peptides in the rat stomach. Gastroenterology 1986; 90: 970–7
   PubMed Web of Science ®Google Scholar
• Schubert M L, Edwards N F, Makhlouf G M. Regulation of gastric somatostatin secretion in the mouse by luminal acidity: a local feedback mechanism. Gastroenterology 1988; 94: 317–22
   PubMed Web of Science ®Google Scholar
• Sandvik A K, Waldum H L. The effect of somatostatin on base-line and stimulated acid secretion and vascular histamine release from the totally isolated vascularly perfused rat stomach. Regul Peptides 1988; 20: 233–9
   PubMedGoogle Scholar
• Haruma K, Sumii K, Okamoto S, et al. Helicobacter pylori infection causes low antral somatostatin content: pathogenesis of inappropriate hypergastrinemia. Gastroenterology 1992; 102A: 80
   Google Scholar
• Murthy U K, Linscheer R, Cho C. The hypergastrinaemia in Helicobacter pylori gastritis is due to a decrease in antral D cell density and D:G cell ratio. Gastroenterology 1992; 102A: 130
   Google Scholar
• Kaneko H, Nakada K, Mitsuma T, et al. Helicobacter pylori infection induces a decrease in immunoreactive somatostatin concentrations of human stomach. Dig Dis Sci 1992; 37: 409–16
   PubMed Web of Science ®Google Scholar
• Moss S F, Legon S, Bishop A E, Polak J M, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930–2
   PubMed Web of Science ®Google Scholar